Article Information
History
- September 25, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Teresa K. Yamana1,*,
- Marta Galanti1,
- Sen Pei1,
- Manuela Di Fusco2,
- Frederick J. Angulo3,
- Mary M. Moran3,
- Farid Khan3,
- David L. Swerdlow3 and
- Jeffrey Shaman1,*
- 1Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, 722 West 168th Street, New York, NY 10032
- 2Health Economics and Outcomes Research, Pfizer, 235 East 42nd Street, NY 10017
- 3Medical Development and Scientific/Clinical Affairs, Pfizer Vaccines, 500 Arcola Road, Collegeville PA 19426
- ↵*Correspondence to: T.K.Y. (tky2104{at}cumc.columbia.edu) and J.S. (jls106{at}cumc.columbia.edu)